Immunotherapy has offered new opportunities to treat head and neck squamous cell
carcinoma (HNSCC); however, its clinical applications are hindered by modest therapeutic …

The efficacy of combination immunotherapy has been limited by tumor specificity and
immune‐related adverse events (irAEs). Herein, we report the development of polymeric …

Inducing immunogenic cell death (ICD) by sonodynamic therapy (SDT) is promising for
cancer immunotherapy, which however is inefficient due to oxygen depletion that …

Sonodynamic therapy (SDT) is emerging as a non-invasive strategy to eradicate tumors, but
its therapeutic efficacy is still not ideal. To achieve more effective SDT, water insoluble …

Nanomedicine holds promise to enhance cancer immunotherapy; however, its potential to
elicit highly specific anti-tumor immunity without compromising immune tolerance has yet to …

Despite the great promises of sonodynamic therapy (SDT) in combination cancer therapy, its
clinical applications are hindered by the “always‐on” pharmacological activities of …

Although the combinations of immunotherapy with other therapies can offer promising
possibility to sensitize tumors to various immunotherapeutic strategies for amplified …

The therapeutic effect of cancer immunotherapy is restrained by limited patient response
rate caused by 'cold'tumors with an intrinsically immunosuppressive tumor …

Pharmacological activation of the stimulator of interferon genes (STING) pathway has
become a promising strategy for cancer immunotherapy. However, the insufficient tumorous …

Sonodynamic therapy (SDT) is a promising non‐invasive therapeutic modality to treat deep‐
seated tumors owing to the good tissue penetration ability and spatiotemporal controllability …